College of Nursing Dean Greer Glazer Joins Board of The Sullivan Alliance
Greer Glazer, PhD, dean of the University of Cincinnati (UC) College of Nursing, has joined the Board of Directors of The Sullivan Alliance to Transform the Health Professions.
"As we look forward to the future, we recognize the need for expanded interprofessional training and care delivery to address the health demands of our nation, said The Sullivan Alliance Chairman and CEO Louis Sullivan, MD. "As a part of our board of directors, Dr. Glazers strong leadership skills and deep engagement in diversity efforts will be a tremendous asset to our efforts to increase diversity across the health workforce.
Glazer has been involved in efforts to diversify the nursing workforce since 2004 with significant HRSA foundation and health care funding for pipeline institutional projects. Her professional organization involvement includes AACN Board of Directors, the Coalition Urban Serving Universities Urban Health Initiative Committee, and past chairperson of the American Association of Colleges of Nursing Executive Development Series.
"I am honored and humbled to serve on such an important board under the leadership of an icon, Dr. Louis Sullivan, said Glazer. "I hope that in some small way I can contribute to the diversification of the health care workforce in the United States which is sorely needed. Glazer is UCs seventh dean of nursing and 14th senior leader of the college, which was led for its first 51 years by a superintendent or director.
Tags
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.